Table 1.

 

Factors		Cases	RFS univariate	RFS multivariable	OS univariate	OS multivariable
pT Stage	T3 / Tis-T2	51 / 27	HR = 1.36 P = 0.392 95%CI:0.68–2.88		HR = 1.72 P = 0.169 95%CI:0.80–4.12
pN Stage	N1 / N0	46 / 31 (1)	HR = 2.39 P = 0.017 95%CI:1.16–5.39	HR = 1.99 P = 0.080 95%CI: 0.92–4.69	HR = 2.71 P = 0.013 95%CI:1.22–6.83	HR = 2.11 P = 0.089 95%CI:0.90–5.58
Differentiation	Poor / Moderate-Well	12 / 66	HR = 1.75 P = 0.186 95%CI: 0.74–3.67		HR = 2.56 P = 0.036 95%CI:0.68–2.88	HR = 1.55 P = 0.349 95%CI:0.59–3.64
Lymphatic invasion	Positive / Negative	58 / 20	HR = 5.18 P < 0.001 95%CI: 1.86–21.55	HR = 3.56 P = 0.020 95%CI: 1.20–15.30	HR = 6.47 P < 0.001 95%CI:1.95–40.06	HR = 4.27 P = 0.019 95%CI:1.23–27.04
Vessel invasion	Positive / Negative	29 / 49	HR = 1.89 P = 0.062 95%CI: 0.97–3.66		HR = 1.28 P = 0.500 95%CI:0.61–2.60
Intraepithelial spread	Positive / Negative	33 / 37 (8)	HR = 1.15 P = 0.690 95%CI: 0.57–2.33		HR = 1.12 P = 0.759 95%CI:0.53-2.43
PAX5 QMSP	High / Low	26 / 52	HR = 2.54 P = 0.006 95%CI:1.31–4.93	HR = 2.67 P = 0.006 95%CI: 1.34–5.29	HR = 3.16 P = 0.002 95%CI:1.55–6.59	HR = 3.12 P = 0.003 95%CI:1.48–6.70

(number): unknown